1. Thevasundari, S., & Rajendran, A. (2011). Antibacterial potential and phytochemical analysis of Heterostemma tanjorense (wight and arn). World Journal of Science and Technology, 1(11), 39–45.
2. Kawasaki, E. S., & Player, A. (2005). Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine, 1, 101–109.
3. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61, 69–90.
4. Wei, Q., Mu, K., Li, T., Zhang, Y., Yang, Z., Jia, X., Zhao, W., Huai, W., Guo, P., & Han, L. (2014). Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Laboratory Investigation, 94(1), 52–62.
5. Zhu, X. L., Wang, Y. L., Chen, J. P., Duan, L. L., Cong, P. F., Qu, Y. C., Ling, J. L., & Zhang, M. X. (2014). Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition. Tumour Biology, 35(2), 1627–1635.